Is neuromyelitis optica associated with human leukocyte antigen?

Multiple Sclerosis

Volumn 15, Issue 5, 2009, Pages 571-579

  Zéphir, Hélène ^a   Fajardy, I ^b   Outteryck, O ^a   Blanc, F ^c   Roger, N ^b   Fleury, M ^c   Rudolf, G ^c   Marignier, R ^d,e   Vukusic, S ^d   Confavreux, C ^d   Vermersch, P ^a   de Seze, J ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Centre de Biologie Pathologique Biochimie Biologie Moléculaire   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

Alleles; Genetics; HLA; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR2 ANTIGEN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; MALE; MYELOOPTIC NEUROPATHY;

CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA;

EID: 65449158482     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508102085     Document Type: Article

References (33)

1. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility: A critical review. J Neuroimmunol 1994; 54: 1-17.
2. McDonald I. Multiple sclerosis: Epidemiology and HLA association. Ann N Y Acad Sci 1984; 436: 109-117.
3. Eoli M, Pandolfo M, Amoroso A. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families. Eur J Hum Genet 1995; 3: 303-311.
4. Hillert J, Olerup O. Multiple sclerosis is associated with genes within or close to the HLA-Dr-DQ dub-region on a normal DR15DQ6Dw2 haplotype. Neurology 1993; 43: 263-268.
5. Wingerchuk DM, Hogacamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
6. Lucchinetti CF, Mandler RN, McGavern D. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-1461.
7. Takahashi T, Fujihara K, Nakashima I. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre. Brain 2007; 130: 1235-1243.
8. Pittock SJ, Lennon VA, Kreche K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.
9. Lennon VA, Wingerchuk DM, Kryzer TJ. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
10. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
11. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
12. Paty DW, Li DK, Oger JJ. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994; 36: 95-96.
13. Danze PM, Bianchi F, Fajardy I, Rousseaux J. An improved strategy for HLA-DRB1 subtyping by digestion of PCR-amplified DNA with allele-specific restriction endonucleases. Appl Theor Electrophor 1995; 5: 7-13.
14. Marsh SG. Nomenclature for factors of the HLA system, update January 1995. Tissue Antigens 1995; 45: 220-222.
15. Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
16. Marignier R, de Seze J, Vukusic S. NMO-IgG and Devic's neuromyelitis optica: A French experience. Mult Scler 2008; 14: 440-445.
17. Svejgaard A, Jersild CL, Nielsen LS, Bodmer WF. HLA antigens and disease: Statistical and genetic consideration. Tissue Antigens 1974; 4: 95-105.
18. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-253.
19. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 309-311.
20. Bodmer JG, Bodmer WF, Piazza A. Inclusion analysis of Fifth Histocompatibility Testing Workshop sera in 25 populations. Tissue Antigens 1975; 5: 15-66.
21. Martiello M, Lennon VA, Jacob A. NMO-IgG predict the outcome of recurrent optic neuritis. Neurology 2008; 70: 2197-2200.
22. Weinshenker BG, Wingerchuk DM, Vukusic S. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006; 3: 566-569.
23. Misu T, Fujihara K, Nakashima I. Pure optic-spinal form of multiple sclerosis in Japan. Brain 2002; 125: 2460-2468.
24. Ito H, Yamasaki K, Kawano Y. HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 1998; 52: 179-182.
25. Yamasaki K, Horiuchi I, Minohara M. HLA-DPB1*0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies. Brain 1999; 122: 1689-1696.
26. Fukazawa T, Yamasaki K, Ito H. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: Clinical phenotypes and gender as important factors. Tissue Antigens 2000; 55: 199-205.
27. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1084 cases. Neurology 1975; 25: 845-851.
28. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: Comparison between British and Japanese patients. J Neurol Sci 1981; 49: 253-271.
29. Kira JI. Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127.
30. Nakashima I, Fujihara K, Miyazawa I. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.
31. Gregersen PK, Behrens TW. Genetics of autoimmune diseases-disorders of immune homeostasis. Nat Rev Genet 2006; 7: 917-928.
32. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64: 621-649.
33. Schafer PH, Pierce SK, Jardetzky TS. The structure of MHC class II: A role for dimer of dimers. Semin Immunol 1995; 7: 389-398.